Skip to main content
OpenTrials
Completed

NCT Number: NCT02840786

Clinical Study of Stent Versus Direct Atherectomy to Treat Arteriosclerosis Occlusive Disease of Lower Extremity

This is a randomized study comparing stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery)

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gu Yong Quan

Beijing, Beijing Municipality, 100053, China

About this study

This is a randomized study comparing balloon angioplasty adjunctive stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patients were included if they were de novo stenosis>70% or occlusion of the femoropopliteal at least 18 years of age and referred for claudication (Rutherford-Becker class II-III) or critical limb ischemia (Rutherford-Becker class IV-V). They were excluded if they had one or more of the following: 1. Acute or subacute lower limb ischemia; 2. Severe calcification lesions; 3. Total occlusions lesions more significant than 10 cm or total occlusion lesions with a suspicion of subintimal wire recanalization 4. untreated ipsilateral iliac artery stenosis>70%, or the distal runoff artery <1 root; 5. Previously lower extremity intervention or surgical graft artery bypass; 6. Severe renal insufficiency, creatinine level greater than 2.5 mg/dL; 7. The patient's platelet count is less than 100,000/uL, antiplatelet or anticoagulant contraindications to required medications; 8. Patients with immune system diseases or malignant tumours; 9. ongoing active infection 10. decompensated congestive heart failure or acute coronary syndrome; 11. Unwillingness to return for future follow-up visits

Treatment and study plan

plaque excision system

Device

balloon and Stent

Device

Primary outcomes

  1. 12-month Primary Patency Rate

    Time frame: 12 months

    systolic velocity ratio >2.4 as measured by Duplex ultrasound.

Secondary outcomes

  1. Technical success

    Time frame: 1 day

    Technical success was defined as residual stenosis less than 30% by final angiography and/or a flow-limiting dissection.

  2. freedom from clinically-driven TLR

    Time frame: 12 months

    it is defined as thefreedom from clinically-driven target lesion revascularization

  3. Major Adverse Events at 12-month Post Procedure

    Time frame: 12 months

    Major adverse events included death, index limb ischemia, index limb amputation, clinically driven target lesion revascularization , and significant embolic events, which were defined as causing end-organ damage.

  4. 12-month Limb Salvage Rate

    Time frame: 12 months

    Limb Salvage is defined as the freedom from secondary major amputation

Sponsors and collaborators

Lead sponsor

Xuanwu Hospital, Beijing

Other

Collaborators

  • Beijing Chao Yang Hospital
  • Beijing Friendship Hospital

Registry information

Official study title

Occlusive Disease of Lower Extremity

Important dates

Study start
2016
Primary completion
2018
Study completion
2019
First posted
Jul 21, 2016
Registry last updated
Dec 4, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.